| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/11/2002 | CN1368508A Human protein with cancer inhibiting function and its coding sequence |
| 09/11/2002 | CN1368507A Process for purifying stem cell factor |
| 09/11/2002 | CN1368506A Plasmodium fused antigen and its preparing process and usage |
| 09/11/2002 | CN1368384A Genetically engineered vaccine of MUC-1 antigen for human breast cancer |
| 09/11/2002 | CN1090676C Expression systems utilizing autolyzing fusion proteins and novel reducing polypeptide |
| 09/10/2002 | US6448472 Genetic and epigenetic manipulation of ABC transporters and ectophosphatases for the conference of hormone and herbicide resistance |
| 09/10/2002 | US6448471 Nematode-feeding structure specific gene and its application to produce nematode resistant plants |
| 09/10/2002 | US6448470 Mouse has cartilage comprising human col2a1 collagen gene but not mouse col2a1, and a normal skeletal structure |
| 09/10/2002 | US6448469 Production of membrane proteins in the milk of transgenic nonhuman mammals |
| 09/10/2002 | US6448468 Transgenetic mouse which comprises an inactive Peg3 gene, and the use thereof |
| 09/10/2002 | US6448407 Atropisomers of asymmetric xanthene fluorescent dyes and methods of DNA sequencing and fragment analysis |
| 09/10/2002 | US6448391 Ubiquitin-lytic peptide fusion gene constructs with enhanced stability and gene expression |
| 09/10/2002 | US6448390 Mutant protein allows for decreased shedding of the surface protein by suppressing precursor cleavage, while maintaining mutant envelope protein incorporation into a virion |
| 09/10/2002 | US6448389 Human cytomegalovirus DNA constructs and uses therefor |
| 09/10/2002 | US6448386 High molecular weight major outer membrane protein of moraxella |
| 09/10/2002 | US6448382 Loading a mixture of isoforms onto a tsk sulfopropyl cation exchange chromatography column, washing with linear gradient buffer, discarding fraction comprising double clipped isoform and collecting intact and single-clipped isoforms |
| 09/10/2002 | US6448381 DNA encoding heparin-binding growth factor |
| 09/10/2002 | US6448378 Made by preparing a purified solution of monoreactive-amine modified collagen, such as glutaric anhydride derivatized collagen, heating to reduce viscosity and adding the drug to the solution, casting into thin layers, drying into film |
| 09/10/2002 | US6448376 Two new proteins which appear to be new members of the e2f gene family, called e2f-5 |
| 09/10/2002 | US6448375 Active and inactive CC-chemokine receptor |
| 09/10/2002 | US6448374 Production of phosphopeptides from casein |
| 09/10/2002 | US6448234 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/10/2002 | US6448230 Testis expressed polypeptide |
| 09/10/2002 | US6448226 Bacillus thuringiensis strains and their insecticidal proteins |
| 09/10/2002 | US6448224 Antibiotics and methods of using the same |
| 09/10/2002 | US6448221 By administering an adipocyte complement related protein to reduce platelet aggregation |
| 09/10/2002 | US6448087 Method for determining and modifying protein/peptide solubility |
| 09/10/2002 | US6448083 Contacting a mammalian cell with filamentous phage particles presenting a ligand on their surfaces, wherein a vector within the phage encodes a gene product under control of a promoter |
| 09/10/2002 | US6448078 Inhibiting human vpr interacting protein activity in a cell using a nucletide sequence complementary to a portion of the nucleotide sequence that encodes hvip; anticancer agent |
| 09/10/2002 | US6448077 Chimeric and humanized monoclonal antibodies specific to VEGF receptors |
| 09/10/2002 | US6448073 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 09/10/2002 | US6448072 Human transcription factor iia (tfiia) is a cellular factor that, together with additional protein components, regulates the expression of human genes |
| 09/10/2002 | US6448071 Effective competitors to t cell receptors and mhc molecules normally involved in transplant rejection and autoimmune disease |
| 09/10/2002 | US6448070 Recombinant plant viruses, especially their use as immunizing agents which carry antigenic sequences from mammalian or other animal pathogens and their use as a system for increased production of polypeptides of interest |
| 09/10/2002 | US6448060 Alkalothermophilic bacillus that produces a protease inhibitor |
| 09/10/2002 | US6448054 Locally administering to a specific site a fugetactic agent in an amount effective to repel immune cells |
| 09/10/2002 | US6448046 Possessing enhanced stability within a host, enabling the sustained systemic transcription of a nucleotide sequence; accomplished by the use of a dual subgenomic promoter system which reduces the frequency of recombination |
| 09/10/2002 | US6448044 DNA encoding human natural killer cell activating factor II |
| 09/10/2002 | US6448043 Enterococcus faecalis EF040 and uses therefor |
| 09/10/2002 | US6448042 These enzymes have been implicated in a variety of disease processes, including tumor cell invasion, tumor angiogenesis and rheumatoid arthritis |
| 09/10/2002 | US6448041 Colon cancer marker |
| 09/10/2002 | US6448040 Nucleic acid molecules encoding hypusine mutants having the biological activity, of inhibiting cellular proliferation |
| 09/10/2002 | US6448039 Enhancer sequences for late T cell expressed genes |
| 09/10/2002 | US6448036 ribB |
| 09/10/2002 | US6448035 Disorders mediated by disease states associated with suppressed immune function can be treated by administering a soluble form of the negative signaling lir |
| 09/10/2002 | US6448034 Production of variant nisin |
| 09/10/2002 | US6448032 With anti-inflammatory and antipyretic function and involved in a number of diseases such as melanoma and skin cancer |
| 09/10/2002 | US6448022 Method for evaluating inhibition of human chorionic gonadotropin (hcg) production of a subject's trophoblast cells comprising the steps of isolating a regulatory polypeptide inhibits, in a dose dependent manner, the production of hcg by |
| 09/10/2002 | US6448020 Molecules associated with the human suppressor of fused gene |
| 09/10/2002 | US6448019 Inhibit vascular smooth muscle cell activation and/or proliferation or enhance vascular endothelial cell activation and/or proliferation or activate estrogen responsive genes in vascular cells. vasoprotective agents are vasospecific, |
| 09/10/2002 | US6448016 The invention provides purified and isolated dna fragments from bacillus anthracis chromosomal dna, primer sets and probes derived therefrom, as well as kits and detection methods for b. anthracis. the methods of the invention provide |
| 09/10/2002 | US6448011 Isolated nucleic acid, vectors, transformed mammalian cells and non-human transgenic animals that encode and express normal or mutant adrenergic receptor genes. |
| 09/10/2002 | US6448006 Methods and compositions for reducing bacterial tolerance to antibacterials disinfectants and organic solvents |
| 09/10/2002 | US6448005 14723 Receptor, a novel G-protein coupled receptor |
| 09/10/2002 | US6448000 Viral growth and cellular genes that function as tumor suppressors. thus, the present invention provides nucleic acids related to and methods of reducing or preventing viral infection or cancer. the invention also provides methods of |
| 09/10/2002 | US6447996 Polypeptides having galanin receptor activity, genetic material for expressing same, any recombinant cell expressing said polypeptides, and the use thereof, are disclosed. |
| 09/10/2002 | US6447994 A nucleic acid having a first nucleotide sequence encoding an infectious hepatitis c virus, a second nucleotide sequence encoding a ribozyme, and an inducible promoter operably linked to the first and second nucleotide sequences, |
| 09/10/2002 | US6447992 Method for serological typing using type-specific antigens |
| 09/10/2002 | US6447808 Pharmaceutical or veterinary composition for treating wounds comprising milk product extracts including growth factors with basic to neutral isoelectric points |
| 09/10/2002 | US6447786 Cyclic oligopeptides used as controllers of rna transcription factors in staphylococcus grampositive bacteria; prevention of infections |
| 09/10/2002 | US6447784 Genetically engineered salmonella for use in the treatment of cancer |
| 09/10/2002 | US6447783 Compositions comprising FGF9 and use thereof for stimulating cartilage and bone repair |
| 09/10/2002 | US6447781 Administering protein complexes including antigens to humans for prevention of adenocarcinomas, melanomas, neuroblastomas, leukemia, lymphomas and mylomas; immunology; vaccines |
| 09/10/2002 | US6447779 Vaccines comprising polypeptides having antigens and dna sequence codes; antiidiotypic antibodies |
| 09/10/2002 | US6447778 Peptide compositions for the treatment of HIV infection |
| 09/10/2002 | US6447777 Polymerized staphylococcal protein a for treatment of diseases |
| 09/10/2002 | US6447776 Monoclonal antibodies against mutant amino acid sequences generated by genetic deletions or point mutations; detection of cancer |
| 09/10/2002 | US6447775 Prevention of endocytosis and metabolism of amyloid precursor proteins by blocking the binding to low density lipoprotein receptors (lrp); antigens |
| 09/10/2002 | US6447773 Member of ATP dependent protease family, clpL |
| 09/10/2002 | US6447771 Methods and materials relating to novel CD39-like polypeptides |
| 09/10/2002 | US6447769 Modified tumor cells to inhibit transforming growth factor |
| 09/10/2002 | US6447766 Deamidated chemokines |
| 09/10/2002 | CA2288375C Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage |
| 09/10/2002 | CA2258661C Synthetic phosphopeptides for treating bone diseases |
| 09/10/2002 | CA2129339C Inhibitors of thrombosis |
| 09/10/2002 | CA2128247C Vaccines based on streptokinase |
| 09/10/2002 | CA2108678C Production of phosphopeptides from casein |
| 09/10/2002 | CA2073441C Introns and exons of the cystic fibrosis gene and mutations at various positions of the gene |
| 09/09/2002 | CA2340308A1 The process of identification of mutations that control the ability of viruses to replicate and cause disease and the application of these mutations to viral diagnosis and antiviral therapy |
| 09/08/2002 | CA2380716A1 Dna vaccine using liposome-encapsulated plasmid dna encoding for hemagglutinin protein of influenza virus |
| 09/08/2002 | CA2363461A1 Methods for producing proteins by using cell-free protein synthesis systems |
| 09/06/2002 | WO2002069232A2 Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity |
| 09/06/2002 | WO2002069198A2 Hla ligand database utilizing predictive algorithms and methods of making and using same |
| 09/06/2002 | WO2002068694A1 Differentially methylated sequences in pancreatic cancer |
| 09/06/2002 | WO2002068693A2 Method for the systematic discovery of genes and genes discovered thereby |
| 09/06/2002 | WO2002068687A2 Function and application of tob gene in central nervous system of mammal |
| 09/06/2002 | WO2002068682A2 Method for identifying biologically active structures of microbial pathogens |
| 09/06/2002 | WO2002068680A2 Compositions and methods for regulating endogenous inhibitor of atp synthase, including treatment for diabetes |
| 09/06/2002 | WO2002068677A2 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer |
| 09/06/2002 | WO2002068676A2 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
| 09/06/2002 | WO2002068673A2 Hin-1, a tumor suppressor gene |
| 09/06/2002 | WO2002068668A2 Compositions and methods for production cell culture |
| 09/06/2002 | WO2002068667A2 Regulatory elements from rp1 gene and uses thereof |
| 09/06/2002 | WO2002068665A2 Constitutive promoter from arabidopsis |
| 09/06/2002 | WO2002068663A1 Tau-opathy model |
| 09/06/2002 | WO2002068660A1 Fusion protein for the secretion of a protein of interest into the supernatant of the bacterial culture |
| 09/06/2002 | WO2002068655A1 Method of searching for remedy for hepatitis d |
| 09/06/2002 | WO2002068654A2 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 09/06/2002 | WO2002068653A2 Tri-hybrid melanoma antigen |
| 09/06/2002 | WO2002068652A2 Nov-x proteins and nucleic acids encoding same |